Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Some women with PCOS have rare genetic variants linked to the condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Prolactin affects when mice shed and grow hair.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Prolactin affects when mice shed and grow hair.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Testosterone therapy increases bone density in older men with low testosterone levels.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.